₹27.5
▲ +1.84 +7.17%
17 Jul 2026
BSE Listed
Medico Intercontinental Limited (539938)
Volume: 175Avg Vol 1W: 708Avg Vol 1M: 10,86052W Range:₹20.61₹43
Key Ratios
Checked just nowMarket Cap₹28 Cr
Current Price₹27.5
Previous Close₹25.66
High / Low (52w)₹43 / ₹20.61
Volume175
Avg Vol (1W)708
Avg Vol (1M)10,860
Stock P/E—
Book Value₹46.89
Dividend Yield0%
ROE-6.83%
ROA-9.43%
Revenue (TTM)—
Revenue Growth—
Profit Margin-380.54%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.59
Debt / Equity0.23
50 DMA₹25.48
200 DMA₹31.24
Day change+7.17%
Price Chart
₹27.5▼ 28.39% · 1Y
2025-07-172026-07-17
20-day avg volume: 12K shares
Pros
- Company is almost debt-free.
- Revenue grew 34% YoY.
- Net profit is growing year over year.
- Stock trades below its book value.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹19 Cr | ₹36 Cr | ₹18 Cr | ₹21 Cr | ₹21 Cr | ₹20 Cr | ₹20 Cr | ₹22 Cr |
| EBITDA | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹0 Cr | ₹-2 Cr | ₹1 Cr | ₹0 Cr |
| Net Profit | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹-1 Cr | ₹-2 Cr | ₹0 Cr | ₹-1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹10 Cr | ₹82 Cr | ₹70 Cr | ₹75 Cr | ₹77 Cr | ₹72 Cr | ₹96 Cr |
| EBITDA | ₹0 Cr | ₹1 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹8 Cr |
| Net Profit | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr |
| EPS | 0.09 | 2.27 | 7.25 | 7.93 | 9.54 | 5.61 | 3.95 | 5.06 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹4 Cr | ₹9 Cr | ₹36 Cr | ₹31 Cr | ₹32 Cr | ₹59 Cr | ₹56 Cr | ₹76 Cr |
| Total Liabilities | ₹1 Cr | ₹5 Cr | ₹30 Cr | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹11 Cr | ₹27 Cr |
| Equity | ₹3 Cr | ₹4 Cr | ₹6 Cr | ₹10 Cr | ₹13 Cr | ₹41 Cr | ₹45 Cr | ₹49 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹1 Cr | ₹-9 Cr | ₹7 Cr | ₹5 Cr | ₹-9 Cr | ₹7 Cr | ₹-5 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-1 Cr | ₹-5 Cr | ₹-9 Cr | ₹-2 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹13 Cr | ₹-5 Cr | ₹-1 Cr | ₹20 Cr | ₹0 Cr | ₹9 Cr |
| Free Cash Flow | ₹0 Cr | ₹1 Cr | ₹-9 Cr | ₹7 Cr | ₹5 Cr | ₹-9 Cr | ₹7 Cr | ₹-5 Cr |
Shareholding
Promoter 58.51% Institutions 0% Public 41.49%
Efficiency & Working Capital
ROCE-1%
Interest Coverage8
Dividend Payout—
Debtor Days125 d
Inventory Days35 d
Payable Days28 d
Cash Conversion Cycle132 d
Working Capital Days160 d
Shareholding Details
As of 2026-06-30
Promoter58.5%
FII0%
DII0%
Institutions0%
Public41.5%
Promoter Pledge0%
No. of Shareholders3,489
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.8% | 55.1% | 55.1% | 55.1% | 55.1% | 55.2% | 55.2% | 55.2% | 55.2% | 57.1% | 57.1% | 58.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 45.2% | 44.9% | 44.9% | 44.9% | 44.9% | 44.8% | 44.8% | 44.8% | 44.8% | 42.9% | 42.9% | 41.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,134 | 1,119 | 3,499 | 3,465 | 3,577 | 3,759 | 3,731 | 3,696 | 3,625 | 3,575 | 3,499 | 3,489 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Shah Samir | Shareholding of Promoter and Promoter Group | 47.8% | 47,76,999 |
| Dilipkumar Bhogilal Shah | Shareholding of Promoter and Promoter Group | 10.7% | 10,74,397 |
| Lalita . | Public Shareholding | 1.5% | 1,50,000 |
| Dd Master Huf . | Public Shareholding | 1.2% | 1,23,575 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Shah Samir | 0 | 0% | 2026-06-30 |
| Dilipkumar Bhogilal Shah | 0 | 0% | 2026-06-30 |
| Lalita . | 0 | 0% | 2026-06-30 |
| Dd Master Huf . | 0 | 0% | 2026-06-30 |
| Shah Samir | 0 | 0% | 2026-03-31 |
| Dilipkumar Bhogilal Shah | 0 | 0% | 2026-03-31 |
| Lalita . | 0 | 0% | 2026-03-31 |
| Dd Master Huf . | 0 | 0% | 2026-03-31 |
| Share India Securities Limited | 0 | 0% | 2026-03-31 |
| Shah Samir | 0 | 0% | 2025-12-31 |
| Dilipkumar Bhogilal Shah | 0 | 0% | 2025-12-31 |
| Lalita . | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Tanvi Shah | Chairman & Non Executive Dir. | 2025 |
| Samir Shah | Executive Director & MD | 2025 |
| Ankur Dave | Independent Non Exe. Director | 2025 |
| Priyank Lalitbhai Sancheti | Independent Non Exe. Director | 2025 |
| Swati Vikramkumar Shah | Non Executive Director | 2025 |
| Parshwa Kaushal Shah | Independent Non Exe. Director | 2025 |
| Puneeta Sharma | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Trading | ₹68 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 20 | 10 | 10 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 6 | 0 | 6 | 1 | 28 | 41 |
| 2025 | 0 | 0 | 3 | 0 | 0 | 3 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
3 disclosure(s)
Market24/12/2025 · 1,97,285
Market24/11/2023 · 18,700
Market23/11/2023 · 11,028
Company Information
🌐 www.medicointercontinental.com ↗
📍 213 2nd Floor, Raheja Chambers Nariman Point, Mumbai, Maharashtra, 400021
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search